Exploring the Potential Use of a PBMC-Based Functional Assay to Identify Predictive Biomarkers for Anti-PD-1 Immunotherapy

The absence of reliable, robust, and non-invasive biomarkers for anti- Programmed cell death protein 1 (PD-1) immunotherapy is an urgent unmet medical need for the treatment of cancer patients. No predictive biomarkers have been established based on the direct assessment of T cell functions, the pri...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of molecular sciences Ročník 21; číslo 23; s. 9023
Hlavní autoři:	Bacot, Silvia M., Harper, Taylor A., Matthews, Rebecca L., Fennell, Christie Jane, Akue, Adovi, KuKuruga, Mark A., Lee, Shiowjen, Wang, Tao, Feldman, Gerald M.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 27.11.2020 MDPI
Témata:	Antigens, CD - metabolism Biomarkers Biomarkers - metabolism Cancer Cell Proliferation - drug effects Cytokines Cytokines - biosynthesis Cytomegalovirus Deoxyribonucleic acid DNA FDA approval Flow cytometry Granzymes - metabolism Humans Immunoassay Immunotherapy Leukocytes, Mononuclear - metabolism Lymphocyte Activation - drug effects Lymphocytes Mutation Nivolumab - pharmacology Patients Programmed Cell Death 1 Receptor - metabolism T cell receptors T-Lymphocytes, Regulatory - drug effects T-Lymphocytes, Regulatory - immunology Targeted cancer therapy Th1 Cells - immunology Tissue Donors peripheral blood mononuclear cells cytokines T cells biomarker Nivolumab
ISSN:	1422-0067, 1661-6596, 1422-0067
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!